The Sentinel Group at MEDICA 2025: innovation and expertise serving global diagnostics

24/10/202528/10/2025

From November 17 to 20, 2025, the Sentinel Group — composed of Sentinel Diagnostics, Eureka Lab Division, and PRIMA Lab — will take part in MEDICA, the world’s leading international trade fair for the medical and diagnostic sectors. Held annually in Düsseldorf, MEDICA brings together global industry leaders, healthcare professionals, researchers, and institutions from around the world. 📍 Where to find us: Hall 3 – Stand 3D16 MEDICA: The global benchmark for innovation in diagnostics and healthcare With more than 5,000 exhibitors from over 70 […]

Sentinel Diagnostics at GISCoR 2025: new solutions for gastrointestinal diagnostics

24/10/202524/10/2025

Sentinel Diagnostics will be among the key participants at GISCoR 2025, the 18th National Congress of the Italian Group for Colorectal Cancer Screening, taking place on November 6–7, 2025, at the T Hotel in Cagliari. The congress is one of the most important national events for professionals involved in the prevention and early diagnosis of colorectal cancer, offering a high-level exchange among experts, researchers, and healthcare professionals from all over Italy. Congress Focus: Centralization, Quality, and […]

Sentinel Diagnostics at SIBioC 2025: innovation and quality in laboratory diagnostics

24/10/202524/10/2025

From November 5 to 7, 2025, Sentinel Diagnostics will take part in the 57th edition of SIBioC – National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, the key event for professionals, researchers, and companies operating in the field of laboratory diagnostics. The event will be held in Florence, at the Palazzo dei Congressi, and will once again offer a rich program of scientific meetings, thematic sessions, round tables, and discussions dedicated to the technological and clinical evolution of biochemistry and molecular biology. It will be a valuable opportunity to share experiences, stay up to date on the latest innovations, and discuss the new challenges of the field with a community of qualified experts and professionals. 📍 Congress dates and times: Wednesday, November […]

FIT vs blood-based testing: our FOB Gold proves to be the superior choice

18/06/202520/06/2025

A recent comparison between the cfDNA blood test (cell-free DNA) and our FOB Gold (Fecal Immunochemical Test – FIT) highlighted the superiority of FIT in detecting advanced precancerous lesions (APCL) while maintaining high specificity. More specifically, the study published in Cancer Communications (May 2025) shows that: FOB Gold demonstrated more than twice the sensitivity of […]

Sentinel at MedLab Middle East 2024: events agenda

10/10/202324/01/2024

Sentinel Diagnostics acquired Eureka srl Lab Division

08/02/202302/03/2023

We are glad to announce that Sentinel Diagnostics (Sentinel CH. SpA), focused for 40 years on the development and production of in vitro diagnostic kits for clinical chemistry, immunochemistry, fecal testing, and molecular diagnostics, extends its expertise and activities in the field of chromatography and mass spectrometry through the acquisition of EUREKA S.r.l.- LAB DIVISION […]

COVID-19, Cold and Flu: How to Distinguish Them?

26/10/202227/10/2022

Why is it important to monitor infections in transplant patients?

23/09/202223/09/2022

Organ Donation Awareness Campaign

21/09/202221/09/2022

Sentinel Diagnostics launches the new SENTiFIT®800, a new completely automated and high-throughput instrument for fecal tests

16/06/202218/06/2022

We are glad to announce the launch of new SENTiFIT®800, the first completely automated, high-throughput instrument for fecal tests. SENTiFIT®800 is particularly suitable for FIT screening programs and laboratories that process high volume of samples. It allows to: Satisfy high-throughput needs Reduce the operator hands-on time Increase the laboratory efficiency SENTiFIT®800 joins the range of […]